Evidence map›Paper›PMID 40542660›Full record

ArticleClinical genetics2026

Highly Variable Expressivity of a CNV Deletion Involving TBX4 in Three Deceased Siblings With Lung Developmental Disorder and Their Mildly Affected Mother and Grandfather.

Przemyslaw Szafranski, Tomasz Gambin, Michal Kadlof, Michał Denkiewicz, Dariusz Plewczynski, Hyun Jeong Kim, Gail Deutsch, Nahir Cortes-Santiago, Salmo Raskin, Paweł Stankiewicz

Abstract readCase Reports
In one paragraph

Article in Clinical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Przemyslaw SzafranskiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Tomasz GambinInstitute of Computer Science, Warsaw University of Technology, Warsaw, Poland.
Michal KadlofFaculty of Mathematics and Information Science, Warsaw University of Technology, Warsaw, Poland.
Michał DenkiewiczFaculty of Mathematics and Information Science, Warsaw University of Technology, Warsaw, Poland.
Dariusz PlewczynskiFaculty of Mathematics and Information Science, Warsaw University of Technology, Warsaw, Poland.ORCID 0000-0002-3840-7610
Hyun Jeong KimDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Gail DeutschDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.
Nahir Cortes-SantiagoDepartment of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA.
Salmo RaskinLaboratorio Genetika, and Postgraduate Program in Child and Adolescent, Department of Pediatrics, Federal University of Paraná, Curitiba, Brazil.
Paweł StankiewiczDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-6456-7490

Funding

Etiology and pathogenesis of lethal lung developmental disorders in neonatesR01HL165301 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI PAWEL STANKIEWICZ · 2023 to 2026
$3.1M
National Science Centre, Poland 2020/37/B/NZ2/03757NHLBI NIH HHS R01 HL165301Politechnika Warszawska
6 · The paper itself

Abstract

Single nucleotide variants (SNVs) and copy-number variant (CNV) deletions involving TBX4 have been associated with pulmonary arterial hypertension, ischiocoxopodopatellar syndrome, and lethal lung developmental disorders (LLDDs). Thus far, all large CNV deletions encompassing entire TBX4 have been found to have arisen de novo. Here, we present a three-generation family with three neonate siblings who died within 35-66 days due to histopathologically diagnosed LLDD. Whole-genome sequencing identified an ~108-kb CNV deletion encompassing TBX4 in all three infants. The deletion was also found in their mother with a history of pneumonia and persistent thick upper airway secretions and in the maternal grandfather who had surgically corrected genu valgum. RT-qPCR from the proband's lung biopsy showed a decrease of TBX4 transcript level greater than 50%, suggesting additional deregulation of TBX4 expression. Computational analyses of the TBX4 super-enhancer identified 15 candidate noncoding hypomorphic SNVs transmitted to the children exclusively from their father and absent in their mother and maternal grandfather. We show that SNV rs35827636T > C, previously proposed as potentially hypomorphic in an unrelated AcDys patient, reduced transcriptional activity of the TBX4 promoter in an episomal reporter assay. Moreover, Hi-C analysis predicted inter-TAD interaction between the TBX4 super-enhancer and its promoter-proximal region. Our data further demonstrate complex compound inheritance of LLDDs and resulting challenges for genetic counseling.

Indexed as

DNA Copy Number VariationsLung DiseasesT-Box Domain ProteinsFemaleHumansInfantInfant, NewbornLungMaleMothersPedigreePolymorphism, Single NucleotideSequence DeletionSiblingsT-Box Domain ProteinsTBX4 protein, human3D chromatin structure modelingdosage sensitivitygenomics of lung developmenthaploinsufficiencyT‐box transcription factor

Identifiers

PMID40542660
PMCPMC12269481

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.